c-Met Kinase Inhibitor III

INQUIRY Add to cart

For Research Use Only | Not For Clinical Use

CAT	IAR42415667
Molecular Weight	419.28

Description	The c-Met Kinase Inhibitor III controls the biological activity of c-Met.
Solubility	DMSO: 50 mg/mL
Assay	≥95% (HPLC)
Color	white
Form	solid
Size	2MG
Storage Conditions	-20C

[Research Progress of HGF/c-MET Inhibitor in the Treatment of Non-small Cell Lung Cancer]

Tao Jiang, Caicun Zhou

Zhongguo Fei Ai Za Zhi. 2015 Apr;18(4):240-4.

PMID: 25936889

ARQ-197, an Oral Small-Molecule Inhibitor of c-Met for the Treatment of Solid Tumors

Rakesh Bagai, Weiwen Fan, Patrick C Ma

IDrugs. 2010 Jun;13(6):404-14.

PMID: 20506063

Crizotinib, a Small-Molecule Dual Inhibitor of the c-Met and ALK Receptor Tyrosine Kinases

Scott J Rodig, Geoffrey I Shapiro

Curr Opin Investig Drugs. 2010 Dec;11(12):1477-90.

PMID: 21154129

Does c-Met Remain a Rational Target for Therapy in Patients With EGFR TKI-resistant Non-Small Cell Lung Cancer?

Yi-Long Wu, Ross Andrew Soo, Giuseppe Locatelli, Uz Stammberger, Giorgio Scagliotti, Keunchil Park

Cancer Treat Rev. 2017 Dec;61:70-81.

PMID: 29121501

Prognostic Factors of Refractory NSCLC Patients Receiving Anlotinib Hydrochloride as the Third- Or Further-Line Treatment

Jing Wang, Yizhuo Zhao, Qiming Wang, Li Zhang, Jianhua Shi, Zhehai Wang, Ying Cheng, Jianxing He, Yuankai Shi, Hao Yu, Yang Zhao, Weiqiang Chen, Yi Luo, Xiuwen Wang, Kejun Nan, Faguang Jin, Jian Dong, Baolan Li, etc.

Cancer Biol Med. 2018 Nov;15(4):443-451.

PMID: 30766754

* Products or Services Interested: c-Met Kinase Inhibitor III ()
* Your question
* Name
* Email
Verification Code

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.

Online Inquiry